AB Glyphosat klar-til-brug

Primær information

  • Handelsnavn:
  • AB Glyphosat klar-til-brug Flydende middel
  • Lægemiddelform:
  • Flydende middel
  • Sammensætning:
  • 7,2 g/l glyphosat
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • AB Glyphosat klar-til-brug Flydende middel
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Udgået
  • Autorisationsnummer:
  • 570-34
  • Sidste ændring:
  • 07-02-2018
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.

16-6-2017

 Eleven new substances on the list of euphoriant substances

Eleven new substances on the list of euphoriant substances

On 15 June 2017, 11 new substances were included in annex 1 of executive order no. 557 of 31 May 2011 on euphoriant substances issued by the Danish Ministry of Health. The information is primarily relevant to companies authorised to deal with euphoriant substances. As from 15 June 2017, the following substances are included in schedule B: 0. AB-CHMINACA (N-(1-aminocarbonyl-2-methylpropyl)-1-(cyclohexylmethyl)-1H-indazol-3-carboxamid). 15 b. AMB-FUBINACA (N-(1-methoxycarbonyl-2-methylpropyl)-1-(...

Danish Medicines Agency

17-4-2018

Bretaris Genuair (AstraZeneca AB)

Bretaris Genuair (AstraZeneca AB)

Bretaris Genuair (Active substance: aclidinium bromide) - Centralised - Yearly update - Commission Decision (2018)2345 of Tue, 17 Apr 2018

Europe -DG Health and Food Safety

17-4-2018

Eklira Genuair (AstraZeneca AB)

Eklira Genuair (AstraZeneca AB)

Eklira Genuair (Active substance: aclidinium bromide) - Centralised - Yearly update - Commission Decision (2018)2347 of Tue, 17 Apr 2018

Europe -DG Health and Food Safety

10-4-2018

Kineret (Swedish Orphan Biovitrum AB (publ))

Kineret (Swedish Orphan Biovitrum AB (publ))

Kineret (Active substance: Anakinra) - Centralised - 2-Monthly update - Commission Decision (2018)2188 of Tue, 10 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/363/II/56

Europe -DG Health and Food Safety

26-3-2018

Lokelma (AstraZeneca AB)

Lokelma (AstraZeneca AB)

Lokelma (Active substance: sodium zirconium cyclosilicate) - Centralised - Authorisation - Commission Decision (2018)1912 of Mon, 26 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4029

Europe -DG Health and Food Safety

23-3-2018

Faslodex (AstraZeneca AB)

Faslodex (AstraZeneca AB)

Faslodex (Active substance: Fulvestrant) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)1898 of Fri, 23 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/540/T/63

Europe -DG Health and Food Safety

5-2-2018

EU/3/08/553 (Pharma Gateway AB)

EU/3/08/553 (Pharma Gateway AB)

EU/3/08/553 (Active substance: Recombinant fusion protein of circulary-permuted IL-4 and pseudomonas exotoxin A, [IL-4(38-37)-PE38KDEL]) - Transfer of orphan designation - Commission Decision (2018)699 of Mon, 05 Feb 2018 European Medicines Agency (EMA) procedure number: EMA/OD/004/08/T/01

Europe -DG Health and Food Safety

15-1-2018

Daliresp (AstraZeneca AB)

Daliresp (AstraZeneca AB)

Daliresp (Active substance: roflumilast) - Centralised - Withdrawal - Commission Decision (2018)198 of Mon, 15 Jan 2018

Europe -DG Health and Food Safety

15-1-2018

Libertek (AstraZeneca AB)

Libertek (AstraZeneca AB)

Libertek (Active substance: roflumilast) - Centralised - Withdrawal - Commission Decision (2018)197 of Mon, 15 Jan 2018

Europe -DG Health and Food Safety

10-1-2018

Fasenra (AstraZeneca AB)

Fasenra (AstraZeneca AB)

Fasenra (Active substance: benralizumab) - Centralised - Authorisation - Commission Decision (2018) 121 of Wed, 10 Jan 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4433

Europe -DG Health and Food Safety

22-12-2017

Ebymect (AstraZeneca AB)

Ebymect (AstraZeneca AB)

Ebymect (Active substance: dapagliflozin / metformin) - Centralised - 2-Monthly update - Commission Decision (2017)9089 of Fri, 22 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4162/WS/1271G

Europe -DG Health and Food Safety

22-12-2017

Xigduo (AstraZeneca AB)

Xigduo (AstraZeneca AB)

Xigduo (Active substance: dapagliflozin/metformin) - Centralised - 2-Monthly update - Commission Decision (2017)9087 of Fri, 22 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2672/WS/1271/G

Europe -DG Health and Food Safety

20-12-2017

Masipro (AB Science)

Masipro (AB Science)

Masipro (Active substance: masitinib) - Centralised - Refusal of marketing authorisation - Commission Decision (2017)8995 of Wed, 20 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4159

Europe -DG Health and Food Safety

14-12-2017

EU/3/17/1947 (NeuroVive Pharmaceutical AB)

EU/3/17/1947 (NeuroVive Pharmaceutical AB)

EU/3/17/1947 (Active substance: 2-isopropyl-3H-naphtho[1,2-d]imidazole-4,5-dione) - Orphan designation - Commission Decision (2017)8779 of Thu, 14 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/132/17

Europe -DG Health and Food Safety

13-12-2017

Zyclara (Meda AB)

Zyclara (Meda AB)

Zyclara (Active substance: imiquimod) - Centralised - 2-Monthly update - Commission Decision (2017)8702 of Wed, 13 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2387/II/13

Europe -DG Health and Food Safety

12-12-2017

Xiapex (Swedish Orphan Biovitrum AB (publ))

Xiapex (Swedish Orphan Biovitrum AB (publ))

Xiapex (Active substance: collagenase clostridium histolyticum) - PSUSA - Modification - Commission Decision (2017)8604 of Tue, 12 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2048/PSUSA/871/201702

Europe -DG Health and Food Safety

28-11-2017

Nuwiq (Octapharma AB)

Nuwiq (Octapharma AB)

Nuwiq (Active substance: simoctocog alfa) - Referral - Commission Decision (2017)7982 of Tue, 28 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2813/A31/15

Europe -DG Health and Food Safety

20-11-2017

ZEP ROUND ONE AB (Chloroxylenol) Liquid [Zep Inc.]

ZEP ROUND ONE AB (Chloroxylenol) Liquid [Zep Inc.]

Updated Date: Nov 20, 2017 EST

US - DailyMed

10-11-2017

EU/3/17/1935 (Edvince AB)

EU/3/17/1935 (Edvince AB)

EU/3/17/1935 (Active substance: 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene) - Orphan designation - Commission Decision (2017)7557 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/120/17

Europe -DG Health and Food Safety

10-11-2017

EU/3/17/1945 (Medical Need Europe AB)

EU/3/17/1945 (Medical Need Europe AB)

EU/3/17/1945 (Active substance: Tiratricol) - Orphan designation - Commission Decision (2017)7567 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/128/17

Europe -DG Health and Food Safety

24-10-2017

AB SKINCARE ACNE SPOT TREATMENT (Benzoyl Peroxide) Cream [Norris Ltd]

AB SKINCARE ACNE SPOT TREATMENT (Benzoyl Peroxide) Cream [Norris Ltd]

Updated Date: Oct 24, 2017 EST

US - DailyMed

24-10-2017

ZEP TRANQ MDW AB FOAM (Benzalkonium Chloride) Liquid [Zep Inc.]

ZEP TRANQ MDW AB FOAM (Benzalkonium Chloride) Liquid [Zep Inc.]

Updated Date: Oct 24, 2017 EST

US - DailyMed

18-10-2017

EU/3/17/1914 (Pharma Gateway AB)

EU/3/17/1914 (Pharma Gateway AB)

EU/3/17/1914 (Active substance: (S)-3-((S)-2-(2-((2,6-difluorophenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid) - Orphan designation - Commission Decision (2017)7047 of Wed, 18 Oct 2017 European Medicines Agency (EMA) procedure number: EMA/OD/079/17

Europe -DG Health and Food Safety

18-10-2017

EU/3/17/1931 (ITB-MED AB)

EU/3/17/1931 (ITB-MED AB)

EU/3/17/1931 (Active substance: Siplizumab) - Orphan designation - Commission Decision (2017)7064 of Wed, 18 Oct 2017 European Medicines Agency (EMA) procedure number: EMA/OD/104/17

Europe -DG Health and Food Safety

18-10-2017

EU/3/17/1928 (Pharma Gateway AB)

EU/3/17/1928 (Pharma Gateway AB)

EU/3/17/1928 (Active substance: Recombinant adeno-associated viral vector serotype 5 encoding Staphylococcus aureus Cas9 endonuclease and two guide RNAs complementary to two regions of intron 26 of the CEP290 gene) - Orphan designation - Commission Decision (2017)7061 of Wed, 18 Oct 2017 European Medicines Agency (EMA) procedure number: EMA/OD/060/17

Europe -DG Health and Food Safety

18-10-2017

EU/3/17/1918 (CellProtect Nordic Pharmaceuticals AB)

EU/3/17/1918 (CellProtect Nordic Pharmaceuticals AB)

EU/3/17/1918 (Active substance: Autologous ex-vivo-expanded peripheral polyclonal lymphocytes enriched in activated natural killer cells) - Orphan designation - Commission Decision (2017)7051 of Wed, 18 Oct 2017 European Medicines Agency (EMA) procedure number: EMA/OD/125/17

Europe -DG Health and Food Safety

17-10-2017

ZEP BLUE SKY AB (Benzalkonium Chloride) Liquid [Zep Inc.]

ZEP BLUE SKY AB (Benzalkonium Chloride) Liquid [Zep Inc.]

Updated Date: Oct 17, 2017 EST

US - DailyMed

17-10-2017

ZEP MANGO AB (Benzalkonium Chloride) Liquid [Zep Inc.]

ZEP MANGO AB (Benzalkonium Chloride) Liquid [Zep Inc.]

Updated Date: Oct 17, 2017 EST

US - DailyMed

6-10-2017

ZEP APPLAUD AB (Chloroxylenol) Liquid [Zep Inc.]

ZEP APPLAUD AB (Chloroxylenol) Liquid [Zep Inc.]

Updated Date: Oct 6, 2017 EST

US - DailyMed

4-10-2017

FUZION AB FOAM (Benzalkonium Chloride) Liquid [Zep Inc.]

FUZION AB FOAM (Benzalkonium Chloride) Liquid [Zep Inc.]

Updated Date: Oct 4, 2017 EST

US - DailyMed

28-8-2017

BYDUREON (AstraZeneca AB)

BYDUREON (AstraZeneca AB)

BYDUREON (Active substance: exenatide) - Centralised - 2-Monthly update - Commission Decision (2017)5937 of Mon, 28 Aug 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2020/II/41

Europe -DG Health and Food Safety

28-8-2017

EU/3/17/1904 (Axelar AB)

EU/3/17/1904 (Axelar AB)

EU/3/17/1904 (Active substance: Picropodophyllin) - Orphan designation - Commission Decision (2017)5913 of Mon, 28 Aug 2017 European Medicines Agency (EMA) procedure number: EMA/OD/068/17

Europe -DG Health and Food Safety

28-8-2017

Fluenz Tetra (AstraZeneca AB)

Fluenz Tetra (AstraZeneca AB)

Fluenz Tetra (Active substance: influenza vaccine (live attenuated, nasal)) - Centralised - Variation - Commission Decision (2017)5938 of Mon, 28 Aug 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2617/II/72

Europe -DG Health and Food Safety

24-7-2017

Qtern (AstraZeneca AB)

Qtern (AstraZeneca AB)

Qtern (Active substance: saxagliptin / dapagliflozin) - Centralised - 2-Monthly update - Commission Decision (2017)5254 of Mon, 24 Jul 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4057/IB/07

Europe -DG Health and Food Safety

24-7-2017

Forxiga (AstraZeneca AB)

Forxiga (AstraZeneca AB)

Forxiga (Active substance: dapagliflozin) - PSUSA - Modification - Commission Decision (2017)5244 of Mon, 24 Jul 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/00010029/201610

Europe -DG Health and Food Safety

17-7-2017

Edistride (AstraZeneca AB)

Edistride (AstraZeneca AB)

Edistride (Active substance: dapagliflozin) - PSUSA - Modification - Commission Decision (2017)5090 of Mon, 17 Jul 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/10029/201610

Europe -DG Health and Food Safety

13-7-2017

ORFADIN (Nitisinone) Suspension [Swedish Orphan Biovitrum AB (Publ)
]

ORFADIN (Nitisinone) Suspension [Swedish Orphan Biovitrum AB (Publ) ]

Updated Date: Jul 13, 2017 EST

US - DailyMed

13-7-2017

ORFADIN (Nitisinone) Capsule [SWEDISH ORPHAN BIOVITRUM AB (PUBL)]

ORFADIN (Nitisinone) Capsule [SWEDISH ORPHAN BIOVITRUM AB (PUBL)]

Updated Date: Jul 13, 2017 EST

US - DailyMed

28-6-2017

Onglyza (AstraZeneca AB)

Onglyza (AstraZeneca AB)

Onglyza (Active substance: saxagliptin) - Centralised - 2-Monthly update - Commission Decision (2017)4525 of Wed, 28 Jun 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/1039/WS/1078

Europe -DG Health and Food Safety

28-6-2017

Komboglyze (AstraZeneca AB)

Komboglyze (AstraZeneca AB)

Komboglyze (Active substance: saxagliptin / metformin) - Centralised - 2-Monthly update - Commission Decision (2017)4518 of Wed, 28 Jun 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2059/WS/1078

Europe -DG Health and Food Safety

27-6-2017

Pandemic influenza vaccine H5N1 AstraZeneca (AstraZeneca AB)

Pandemic influenza vaccine H5N1 AstraZeneca (AstraZeneca AB)

Pandemic influenza vaccine H5N1 AstraZeneca (Active substance: Pandemic influenza vaccine (H5N1) (live attenuated, nasal)) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2017)4478 of Tue, 27 Jun 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/3963/T/05

Europe -DG Health and Food Safety

2-6-2017

Elocta (Swedish Orphan Biovitrum AB (publ))

Elocta (Swedish Orphan Biovitrum AB (publ))

Elocta (Active substance: efmoroctocog alfa) - Centralised - Yearly update - Commission Decision (2017)3891 of Fri, 02 Jun 2017

Europe -DG Health and Food Safety

23-5-2017

Brilique (AstraZeneca AB)

Brilique (AstraZeneca AB)

Brilique (Active substance: ticagrelor) - Centralised - Variation - Commission Decision (2017)3540 of Tue, 23 May 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/1241/X/34

Europe -DG Health and Food Safety

26-4-2017

Zinforo (AstraZeneca AB)

Zinforo (AstraZeneca AB)

Zinforo (Active substance: ceftaroline fosamil) - Centralised - Renewal - Commission Decision (2017)2849 of Wed, 26 Apr 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/2252/R-31

Europe -DG Health and Food Safety